Andrew Goldman is a global health lawyer and strategic advisor focused on the intersection of biomedical innovation and equitable access. He routinely counsels funders, international organizations, and research institutions on how contracts concerning the development of medical technologies can be structured to support both innovation as well as affordable access in low- and middle-income countries. He currently consults as a senior advisor for the Medicines Patent Pool, where he was previously an associate counsel, and as a consulting Senior Counsel with the Global Antibiotic Research & Development Partnership. He currently lives in Washington D.C. with his family.
